Page last updated: 2024-09-03

gefitinib and Rhabdomyolysis

gefitinib has been researched along with Rhabdomyolysis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Asano, K; Hayama, N; Ito, Y; Niimi, K; Obayashi, S; Oguma, T; Tanaka, J; Tomomatsu, K; Urata, M1
Deng, Y; Sun, T; Wu, D; Zhang, D1

Other Studies

2 other study(ies) available for gefitinib and Rhabdomyolysis

ArticleYear
Rhabdomyolysis Caused by Gefitinib Overdose.
    Internal medicine (Tokyo, Japan), 2022, May-15, Volume: 61, Issue:10

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Quinazolines; Rhabdomyolysis

2022
EGFR mediated the renal cell apoptosis in rhabdomyolysis-induced model via upregulation of autophagy.
    Life sciences, 2022, Nov-15, Volume: 309

    Topics: Acute Kidney Injury; Animals; Apoptosis; Autophagy; ErbB Receptors; Gefitinib; Glycerol; Kidney; Mice; Myoglobin; Rhabdomyolysis; Up-Regulation

2022